Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2025-12-25 @ 8:07 PM
Study NCT ID:
NCT07272135
Status:
COMPLETED
Last Update Posted:
2025-12-09
First Post:
2022-11-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Selective β2-AR Antagonism in Asthma
Sponsor:
Trio Medicines Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-28
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-16
Completion Date Type:
ACTUAL
First Submit Date:
2022-11-21
First Submit QC Date:
None
Study First Post Date:
2025-12-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-26
Last Update Post Date:
2025-12-09
Last Update Post Date Type:
ESTIMATED